Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Emulex Corporation (“Emulex” or the “Company”) (NYSE: ELX) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders’ approval of executive compensation and an amendment to the Company’s Equity Incentive Plan.

Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on October 9, 2012, the Board of Directors recommends that Emulex’s shareholders vote to approve an amendment to the Company’s 2005 Equity Incentive Plan (the “2005 Plan”) to increase the number of shares that may be issued under the 2005 Plan by an additional 1,500,000 shares. The issuance of the additional shares could have a severe dilutive effect on the shares of Clorox common stock.

Request more information now by clicking here: www.faruqilaw.com/ELX. There is no cost or obligation to you.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in Emulex and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/ELX or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.